1Koho H,Paulie S,Ben-Aissa H et al.Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder(Ⅰ).Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence[J].Cancer Immunol Immunother,1984; 17(3):165-172.
2Imadome K,Shimizu N,Arai A et al.Coexpression of CD40 and CD40 ligand in Epstein-Barr Virus-infected T and NK cells and their role in cell survival[J].J Infect Dis,2005; 192(8):1340-1348.
3Lebre M C,Burwell T,Vieira P L et al.Differential expression of inflammatory chemokines by Th1-and Th2-cell promoting dendritic cells:a role for different mature dendritic cell populations in attracting appropriate effector cells to peripheral sites of inflammation[J].Immunol Cell Biol,2005; 83(5):525-535.
4Loskog A,Dzojic H,Vikman S et al.Adenovirus CD40 ligand gene therapy counteracts immune escape mechanisms in the tumor Microenvironment[J].J Immunol,2004; 172(11):7200-7205.
5Bhushan A,Covey L R.CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes[J].Immunol Res,2001; 24(3):311-324.
6Vowinkel T,Wood K C,Stokes K Y et al.Differential expression and regulation of murine CD40 in regional vascular beds[J].Am J Physiol Heart Circ Physiol,2005;290(2):H631-H639.
7Voorzanger-Rousselot N,Blay J Y.Coexpression of CD40 and CD40L on B lymphoma and carcinoma cells:an autocrine anti-apoptotic role[J].Leuk Lymphoma,2004; 45(6):1239-1245.
8Ghamande S,Hylander B L,Oflazoglu E et al.Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin[J].Cancer Res,2001; 61(20):7556-7562.
9Moore C R,Bishop G A.Differential regulation of CD40-mediated TNF receptor-associated factor degradation in B lymphocytes[J].J Immunol,2005; 175(6):3780-3789.
10Davies C C,Mak T W,Young L S et al.TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells[J].Mol Cell Biol,2005; 25(22):9806-9819.
